TY - JOUR
T1 - Synovial sarcoma a DNA flow cytometric study
AU - El‐Naggar, Adel K.
AU - Ayala, Alberto G.
AU - Abdul‐Karim, Fadi W.
AU - McLemore, Donia
AU - Ballance, William W.
AU - Garnsey, Lisa
AU - Ro, Jae Y.
AU - Batsakis, John G.
N1 - Copyright:
Copyright 2016 Elsevier B.V., All rights reserved.
PY - 1990/5/15
Y1 - 1990/5/15
N2 - The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P < 0.001), tumor size (P < 0.001), and ploidy status (P < 0.003) correlated significantly with patient survival. A marginally significant correlation between mitotic count and patient survival was also observed (P = 0.04). Histologic subtypes (monophasic) versus biphasic), mitotic count, and S-phase by flow cytometry had no significant influence on the clinical outcome of patients with synovial sarcoma in this study. The authors conclude that DNA ploidy analysis is a significant objective probe in the prognostication of patients with synovial sarcoma.
AB - The relationship between DNA content, clinicopathologic findings, and patient survival in synovial sarcoma was investigated. Patient age at diagnosis (P < 0.001), tumor size (P < 0.001), and ploidy status (P < 0.003) correlated significantly with patient survival. A marginally significant correlation between mitotic count and patient survival was also observed (P = 0.04). Histologic subtypes (monophasic) versus biphasic), mitotic count, and S-phase by flow cytometry had no significant influence on the clinical outcome of patients with synovial sarcoma in this study. The authors conclude that DNA ploidy analysis is a significant objective probe in the prognostication of patients with synovial sarcoma.
UR - http://www.scopus.com/inward/record.url?scp=0025281717&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025281717&partnerID=8YFLogxK
U2 - 10.1002/1097-0142(19900515)65:10<2295::AID-CNCR2820651022>3.0.CO;2-7
DO - 10.1002/1097-0142(19900515)65:10<2295::AID-CNCR2820651022>3.0.CO;2-7
M3 - Article
C2 - 2161280
AN - SCOPUS:0025281717
SN - 0008-543X
VL - 65
SP - 2295
EP - 2300
JO - Cancer
JF - Cancer
IS - 10
ER -